THE TRUTH ABOUT: Bristol myers squibb org | History Defined

3 Wide-Moat Stocks That Look Cheap: Biogen, Medtronic, and Bristol-Myers Squibb

: Major stock indices appear heading for weekly gains with the Fed’s first interest rate hike digested easily by investors. However, the market is expected to remain under pressure in the near term. So, because wide-moat companies generally do well in these market conditions, we think cheap wide-moat stocks Bristol-Myers…

StockNews.com · Mar 18, 2022

Bristol-Myers Squibb And 2 Other Stocks Sold By Insiders

The Bank of England increased its key Bank Rate by 25bps to 0.75% during its recent meeting. Investors, meanwhile, focused on some notable insider trades

Benzinga · Mar 17, 2022

Bristol-Myers Squibb Whale Trades For March 03

A whale with a lot of money to spend has taken a noticeably bullish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb (NYSE:BMY) we detected 11 strange trades.

Benzinga · Mar 3, 2022

Looking At Bristol-Myers Squibb's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb (NYSE:BMY) we detected 17 strange trades.

Benzinga · Feb 7, 2022

Bristol-Myers Squibb: Q4 Earnings Insights

  Bristol-Myers Squibb (NYSE:BMY) reported its Q4 earnings results on Friday, February 4, 2022 at 06:59 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 4, 2022

5 Stocks To Watch For February 4, 2022

Some of the stocks that may grab inve3stor focus today are: Wall Street expects Bristol-Myers Squibb Company (NYSE: BMY) to report quarterly earnings at $1.80 per share on revenue of $12.08 billion after the closing bell. Bristol-Myers Squibb shares rose 0.4% to $64.30 in pre-market trading.

Benzinga · Feb 4, 2022

Earnings Outlook For Bristol-Myers Squibb

Bristol-Myers Squibb (NYSE:BMY) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Bristol-Myers Squibb will likely report an Earnings Per Share (EPS) of $1.80.

Benzinga · Feb 3, 2022

Bristol-Myers Squibb's Debt Insights

  Over the past three months, shares of Bristol-Myers Squibb (NYSE:BMY) increased by 9.73%. Before we understand the importance of debt, let us look at how much debt Bristol-Myers Squibb has.

Benzinga · Feb 2, 2022